Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001104659-19-052329

SVP, Chief Commerical Officer gave up 6,990 shares (to pay taxes)

  • SVP, Chief Commerical Officer acquired 20,216 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hickey Benjamin · SVP, Chief Commerical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-01 Exercise or conversion : show line 1 in the form +20,216 20,216 D
2019-10-01 Shares withheld for taxes : show line 2 in the form −6,990 $15.46 $108,065 13,226 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2019-10-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −20,216 $0.00 20,216 60,647 D
Loading xslF345X03/a4.xml…